Therapeutic Potential of Heme Oxygenase-1/carbon Monoxide System Against Ischemia-Reperfusion Injury

By  

Current Pharmaceutical Design, Vol. 23, Iss. 26, 2017-10 ,pp. : 3884-3898

Bentham Science Publishers

Access to resources Recommend Favorite

Where is the Clinical Breakthrough of Heme Oxygenase-1 / Carbon Monoxide Therapeutics?

By  

Current Pharmaceutical Design, Vol. 24, Iss. 20, 2018-06 ,pp. : 2264-2282

Bentham Science Publishers

Access to resources Recommend Favorite

A Critical and Comprehensive Insight on Heme Oxygenase and Related Products Including Carbon Monoxide, Bilirubin, Biliverdin and Ferritin in Type-1 and Type-2 Diabetes

By  

Current Pharmaceutical Design, Vol. 20, Iss. 9, 2014-03 ,pp. : 1370-1391

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-1: A Novel Therapeutic Target in Oxidative Tissue Injuries

By  

Current Medicinal Chemistry, Vol. 11, Iss. 12, 2004-06 ,pp. : 1545-1561

Bentham Science Publishers

Access to resources Recommend Favorite

Heme Oxygenase-Derived Carbon Monoxide Restores Vascular Function in Type 1 Diabetes

By  

Drug Metabolism Letters, Vol. 2, Iss. 4, 2008-12 ,pp. : 290-300

Bentham Science Publishers

Access to resources Recommend Favorite